Astragaloside IV inhibits progression of glioma via blocking MAPK/ERK signaling pathway.
Sign Up to like & getrecommendations! Published in 2017 at "Biochemical and biophysical research communications"
DOI: 10.1016/j.bbrc.2017.07.052
Abstract: Glioma is one of the most common primary brain tumors in adults with a high mortality rate and relapse rate. Thus, finding better effective approaches to treat glioma has become very urgent. Astragaloside IV (AS-IV),… read more here.
Keywords: glioma; signaling pathway; erk signaling; astragaloside inhibits ... See more keywords